Compare ZSTK & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZSTK | EQS |
|---|---|---|
| Founded | 2019 | 1991 |
| Country | Canada | United States |
| Employees | 76 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.0M | 18.9M |
| IPO Year | N/A | 1995 |
| Metric | ZSTK | EQS |
|---|---|---|
| Price | $5.18 | $1.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 13.6K | 11.3K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.73 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.77 | $0.74 |
| 52 Week High | $11.00 | $2.49 |
| Indicator | ZSTK | EQS |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 38.46 |
| Support Level | N/A | $1.28 |
| Resistance Level | $9.45 | $1.99 |
| Average True Range (ATR) | 0.88 | 0.15 |
| MACD | -0.21 | -0.06 |
| Stochastic Oscillator | 8.70 | 7.35 |
ZeroStack Corp is an AI focused asset management company. The company also operates a world-wide pharmaceutical distribution business through its wholly owned subsidiary. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the ecosystem and across the wider AI landscape.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.